SYMBIOSYS valuation report
A sourced history of indicative valuation ranges for SYMBIOSYS, including the model basis, evidence trail, confidence and limitations.
Company overview0885032453
2024 to 2025
sme public accounts
Jul 29, 2026
Latest indicative range
€13k – €35k
2 valuation checkpoints · medium confidence · KBO public registry, raw_company_filings
Estimated value development for this company
Based on filed company accounts and official registry sources. This overview shows a non-binding indication of how this company's value is developing — not an asking price, and not confirmation that the company is for sale.| Fiscal year | Low | Derived range midpoint | High |
|---|---|---|---|
| 2024 | €13k | €23.5k | €34k |
| 2025 | €13k | €24k | €35k |
Refine the valuation and discover action points
Complete the public data for a more precise valuation, the insights behind it, and concrete action points that can increase business value.
Free account · private workspace
01Public range 02Connected accounts 03Business & owner profile 04Method review 05Deal-ready
From filed figures to this valuation range
Indicative public valuation range based on financial year 2025. This historical record does not yet contain an immutable calculation snapshot, so no sector range is reconstructed after the fact. Not a transaction value, asking price or fairness opinion.
- Sources used
- NBB/CBSO for filed annual accounts; KBO for identity and sector classification · 2 public financial years (2024–2025)
- Public earnings basis
- Public EBITDA basis for 2025: €36,927. No private normalisations are assumed.
- Audit status
- The official figures are visible, but this historical valuation has no stored benchmark vintage and calculation bridge yet. Numeric method details remain hidden until a verified recalculation.
- Nature of the range
- This is an automated, indicative public range. It is not a professional fairness opinion and does not replace due diligence or owner-confirmed transaction data.
This automated range is indicative only. It is not a certified valuation or financial, investment, tax or legal advice.